Viral vectors are tools commonly used by molecular biologists to deliver genetic material into cells. This process can be performed inside a living organism or in cell culture. Viruses have evolved specialized molecular mechanisms to efficiently transport their genomes inside the cells they infect.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Viral Vectors industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Plasmid DNA
Viral Vectors
Market Segment by Product Application
Cancers
Inherited Disorders
Viral Infections
Others
Finally, the report provides detailed profile and data information analysis of leading company.
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Viral Vectors consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Viral Vectors market by identifying its various subsegments.
3.Focuses on the key global Viral Vectors manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Viral Vectors with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Viral Vectors submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Viral Vectors Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Viral Vectors Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Viral Vectors Segment by Type
2.1.1 Plasmid DNA
2.1.2 Viral Vectors
2.2 Market Analysis by Application
2.2.1 Cancers
2.2.2 Inherited Disorders
2.2.3 Viral Infections
2.2.4 Others
2.3 Global Viral Vectors Market Comparison by Regions (2017-2027)
2.3.1 Global Viral Vectors Market Size (2017-2027)
2.3.2 North America Viral Vectors Status and Prospect (2017-2027)
2.3.3 Europe Viral Vectors Status and Prospect (2017-2027)
2.3.4 China Viral Vectors Status and Prospect (2017-2027)
2.3.5 Japan Viral Vectors Status and Prospect (2017-2027)
2.3.6 Southeast Asia Viral Vectors Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Viral Vectors Industry Impact
2.5.1 Viral Vectors Business Impact Assessment - Covid-19
2.5.2 Market Trends and Viral Vectors Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Viral Vectors Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Viral Vectors Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Viral Vectors Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Viral Vectors Manufacturer Market Share
3.5 Top 10 Viral Vectors Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Viral Vectors Market
3.7 Key Manufacturers Viral Vectors Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Viral Vectors Industry Key Manufacturers
4.1 BioReliance
4.1.1 Compan Detail
4.1.2 BioReliance Viral Vectors Product Introduction, Application and Specification
4.1.3 BioReliance 164 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 BioReliance News
4.2 Cobra Biologics
4.2.1 Compan Detail
4.2.2 Cobra Biologics Viral Vectors Product Introduction, Application and Specification
4.2.3 Cobra Biologics Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 BioReliance News
4.3 Oxford BioMedica
4.3.1 Compan Detail
4.3.2 Oxford BioMedica Viral Vectors Product Introduction, Application and Specification
4.3.3 Oxford BioMedica Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Oxford BioMedica News
4.4 UniQure
4.4.1 Compan Detail
4.4.2 UniQure Viral Vectors Product Introduction, Application and Specification
4.4.3 UniQure Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 UniQure News
4.5 FinVector
4.5.1 Compan Detail
4.5.2 UniQure Viral Vectors Product Introduction, Application and Specification
4.5.3 FinVector Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 FinVector News
4.6 MolMed
4.6.1 Compan Detail
4.6.2 MolMed Viral Vectors Product Introduction, Application and Specification
4.6.3 MolMed Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 MolMed News
4.7 MassBiologics
4.7.1 Compan Detail
4.7.2 MassBiologics Viral Vectors Product Introduction, Application and Specification
4.7.3 MassBiologics Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Richter-Helm
4.8.1 Compan Detail
4.8.2 Richter-Helm Viral Vectors Product Introduction, Application and Specification
4.8.3 Richter-Helm Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Richter-Helm News
4.9 FUJIFILM Diosynth Biotechnologies
4.9.1 Compan Detail
4.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors Product Introduction, Application and Specification
4.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 FUJIFILM Diosynth Biotechnologies News
4.10 Lonza
4.10.1 Compan Detail
4.10.2 Lonza Viral Vectors Product Introduction, Application and Specification
4.10.3 Lonza Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Lonza News
4.11 Aldevron
4.11.1 Compan Detail
4.11.2 Aldevron Viral Vectors Product Introduction, Application and Specification
4.11.3 Aldevron Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Aldevron News
4.12 Eurogentec
4.12.1 Compan Detail
4.12.2 Eurogentec Viral Vectors Product Introduction, Application and Specification
4.12.3 Eurogentec Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Eurogentec News
4.13 Cell and Gene Therapy Catapult
4.13.1 Company Details
4.13.2 Cell and Gene Therapy Catapult Viral Vectors Product Introduction, Application and Specification
4.13.3 Cell and Gene Therapy Catapult Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Cell and Gene Therapy Catapult News
4.14 Biovian
4.14.1 Compan Detail
4.14.2 Biovian Viral Vectors Product Introduction, Application and Specification
4.14.3 Biovian Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Biovian News
4.15 Brammer Bio
4.15.1 Compan Detail
4.15.2 Brammer Bio Viral Vectors Product Introduction, Application and Specification
4.15.3 Brammer Bio Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Brammer Bio News
4.16 VGXI
4.16.1 Compan Detail
4.16.2 VGXI Viral Vectors Product Introduction, Application and Specification
4.16.3 VGXI Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 VGXI News
4.17 PlasmidFactory
4.17.1 Compan Detail
4.17.2 PlasmidFactory Viral Vectors Product Introduction, Application and Specification
4.17.3 PlasmidFactory Viral Vectors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 PlasmidFactory News
4.18.1 Compan Detail
5 Global Viral Vectors Market Segment by Big Type
5.1 Global Viral Vectors Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Viral Vectors Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Viral Vectors Revenue and Market Share by Big Type (2017-2022)
5.2 Plasmid DNA Sales Growth Rate and Price
5.2.1 Global Plasmid DNA Sales Growth Rate (2017-2022)
5.2.2 Global Plasmid DNA Price (2017-2022)
5.3 Viral Vectors Sales Growth Rate and Price
5.3.1 Global Viral Vectors Sales Growth Rate (2017-2022)
5.3.2 Global Viral Vectors Price (2017-2022)
6 Global Viral Vectors Market Segment by Big Application
6.1 Global Viral Vectors Sales Market Share by Big Application (2017-2022)
6.2 Cancers Sales Growth Rate (2017-2022)
6.3 Inherited Disorders Sales Growth Rate (2017-2022)
6.4 Viral Infections Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global Viral Vectors Forecast
7.1 Global Viral Vectors Revenue, Sales and Growth Rate (2022-2027)
7.2 Viral Vectors Market Forecast by Regions (2022-2027)
7.2.1 North America Viral Vectors Market Forecast (2022-2027)
7.2.2 Europe Viral Vectors Market Forecast (2022-2027)
7.2.3 China Viral Vectors Market Forecast (2022-2027)
7.2.4 Japan Viral Vectors Market Forecast (2022-2027)
7.2.5 Southeast Asia Viral Vectors Market Forecast (2022-2027)
7.2.6 Other Regions Viral Vectors Market Forecast (2022-2027)
7.3 Viral Vectors Market Forecast by Type (2022-2027)
7.3.1 Global Viral Vectors Sales Forecast by Type (2022-2027)
7.3.2 Global Viral Vectors Market Share Forecast by Type (2022-2027)
7.4 Viral Vectors Market Forecast by Application (2022-2027)
7.4.1 Global Viral Vectors Sales Forecast by Application (2022-2027)
7.4.2 Global Viral Vectors Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Viral Vectors Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Viral Vectors Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Viral Vectors
Figure Market Concentration Ratio and Market Maturity Analysis of Viral Vectors
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Viral Vectors Market Size by Big Type
Figure Global Market Share of Viral Vectors by Big Type in 2021
Figure Plasmid DNA Picture (2017-2022)
Global Viral Vectors Market Size by Big Application
Table Global Viral Vectors Market Size by Application
Figure Global Viral Vectors Market Share by Big Application in 2021
Figure Cancers Picture
Figure Inherited Disorders Picture
Figure Viral Infections Picture
Figure Others Picture
Table Global Viral Vectors Comparison by Regions (M USD) (2017-2027)
Figure Global Viral Vectors Market Size (Million US$) (2017-2027)
Figure North America Viral Vectors Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Viral Vectors Revenue (Million US$) Growth Rate (2017-2027)
Figure China Viral Vectors Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Viral Vectors Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Viral Vectors Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Viral Vectors Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Viral Vectors Sales by Manufacturer (2017-2022)
Figure Global Viral Vectors Sales Market Share by Manufacturer in 2021
Table Global Viral Vectors Revenue by Manufacturer (2017-2022)
Figure Global Viral Vectors Revenue Market Share by Manufacturer in 2021
Table Global Viral Vectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Viral Vectors Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Viral Vectors Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Viral Vectors Market
Table Key Manufacturers Viral Vectors Product Type
Table Mergers & Acquisitions Planning
Table BioReliance Company Profile
Table Viral Vectors Product Introduction, Application and Specification of BioReliance
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Cobra Biologics Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Cobra Biologics
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cobra Biologics Recent Development
Table Oxford BioMedica Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Oxford BioMedica
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Oxford BioMedica Main Business
Table Oxford BioMedica Recent Development
Table UniQure Company Profile
Table Viral Vectors Product Introduction, Application and Specification of UniQure
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table UniQure Main Business
Table UniQure Recent Development
Table UniQure Main Business
Table UniQure Recent Development
Table FinVector Company Profile
Table Viral Vectors Product Introduction, Application and Specification of FinVector
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table FinVector Main Business
Table FinVector Recent Development
Table MolMed Company Profile
Table Viral Vectors Product Introduction, Application and Specification of MolMed
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MolMed Main Business
Table MolMed Recent Development
Table MassBiologics Company Profile
Table Viral Vectors Product Introduction, Application and Specification of MassBiologics
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MassBiologics Main Business
Table MassBiologics Recent Development
Table Richter-Helm Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Richter-Helm
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Richter-Helm Main Business
Table Richter-Helm Recent Development
Table FUJIFILM Diosynth Biotechnologies Company Profile
Table Viral Vectors Product Introduction, Application and Specification of FUJIFILM Diosynth Biotechnologies
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table FUJIFILM Diosynth Biotechnologies Main Business
Table FUJIFILM Diosynth Biotechnologies Recent Development
Table Lonza Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Lonza
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lonza Main Business
Table Lonza Recent Development
Table Aldevron Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Aldevron
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aldevron Main Business
Table Aldevron Recent Development
Table Eurogentec Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Eurogentec
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eurogentec Main Business
Table Eurogentec Recent Development
Table Cell and Gene Therapy Catapult Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Cell and Gene Therapy Catapult
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cell and Gene Therapy Catapult Main Business
Table Cell and Gene Therapy Catapult Recent Development
Table Biovian Company Profile
Table Viral Vectors Product Introduction, Application and Specification of Biovian
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biovian Main Business
Table Biovian Recent Development
Table VGXI Company Profile
Table Viral Vectors Product Introduction, Application and Specification of VGXI
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table VGXI Main Business
Table VGXI Recent Development
Table PlasmidFactory Company Profile
Table Viral Vectors Product Introduction, Application and Specification of PlasmidFactory
Table Viral Vectors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table PlasmidFactory Main Business
Table PlasmidFactory Recent Development
Figure Global Viral Vectors Sales and Growth Rate (2017-2022)
Figure Global Viral Vectors Revenue and Growth Rate (2017-2022)
Table Global Viral Vectors Sales by Regions (2017-2022)
Figure Global Viral Vectors Sales Market Share by Regions in 2021
Table Global Viral Vectors Revenue by Regions (2017-2022)
Figure Global Viral Vectors Revenue Market Share by Regions in 2021
Figure North America Viral Vectors Sales and Growth Rate (2017-2022)
Figure Europe Viral Vectors Sales and Growth Rate (2017-2022)
Figure China Viral Vectors Sales and Growth Rate (2017-2022)
Figure Japan Viral Vectors Sales and Growth Rate (2017-2022)
Figure Southeast Asia Viral Vectors Sales and Growth Rate (2017-2022)
Figure Other Regions Viral Vectors Sales and Growth Rate (2017-2022)
Table Global Viral Vectors Sales by Big Type (2017-2022)
Table Global Viral Vectors Sales Market Share by Big Type (2017-2022)
Figure Global Viral Vectors Sales Market Share by Big Type in 2019
Table Global Viral Vectors Revenue by Big Type (2017-2022)
Table Global Viral Vectors Revenue Market Share by Big Type (2017-2022)
Table Global Viral Vectors Revenue Market Share by Big Type in 2019
Figure Global Plasmid DNA Sales Growth Rate (2017-2022)
Figure Global Plasmid DNA Price (2017-2022)
Figure Global Viral Vectors Sales Growth Rate (2017-2022)
Table Global Viral Vectors Sales by Big Application (2017-2022)
Table Global Viral Vectors Sales Market Share by Big Application (2017-2022)
Figure Global Viral Vectors Sales Market Share by Big Application in 2019
Figure Global Cancers Sales Growth Rate (2017-2022)
Figure Global Inherited Disorders Sales Growth Rate (2017-2022)
Figure Global Viral Infections Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Viral Vectors Sales and Growth Rate (2022-2027)
Figure Global Viral Vectors Revenue and Growth Rate (2022-2027)
Table Global Viral Vectors Sales Forecast by Regions (2022-2027)
Table Global Viral Vectors Market Share Forecast by Regions (2022-2027)
Figure North America Sales Viral Vectors Market Forecast (2022-2027)
Figure Europe Sales Viral Vectors Market Forecast (2022-2027)
Figure China Sales Viral Vectors Market Forecast (2022-2027)
Figure Japan Sales Viral Vectors Market Forecast (2022-2027)
Figure Southeast Asia Sales Viral Vectors Market Forecast (2022-2027)
Figure Other Regions Sales Viral Vectors Market Forecast (2022-2027)
Table Global Viral Vectors Sales Forecast by Type (2022-2027)
Table Global Viral Vectors Market Share Forecast by Type (2022-2027)
Table Global Viral Vectors Sales Forecast by Application (2022-2027)
Table Global Viral Vectors Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vectors
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Viral Vectors Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Viral Vectors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Viral Vectors Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Viral Vectors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Viral Vectors Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Viral Vectors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Viral Vectors Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Viral Vectors Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)